Gilead Sciences GILD
NASDAQ GILD
$146.12 +2.68 (+1.87%)
At close: Aug 21, 2026 · 4:00 PM EDT

Gilead Sciences (GILD) Preferred Stock Liabilities (2012 - 2015)

Gilead Sciences' (GILD) quarterly Preferred Stock Liabilities came in at $2.0 million in Q4 2015, down 86.67% YoY from $15.0 million in Q4 2014, and down 50.0% on a QoQ basis from $4.0 million in Q3 2015.

Gilead Sciences (GILD) Preferred Stock Liabilities (2012 - 2015) Analysis & Trends

Gilead Sciences (GILD) has 4 years of Preferred Stock Liabilities data on file, last reported at $2.0 million in Q4 2015.

  • Quarterly Preferred Stock Liabilities fell 86.67% year-over-year to $2.0 million in Q4 2015, while the trailing twelve-month figure through Dec 2015 was $2.0 million (down 86.67% YoY) and the FY2015 annual result came in at $2.0 million, down 86.67% from the prior year.
  • Preferred Stock Liabilities slipped to $2.0 million in Q4 2015, from $4.0 million in the prior quarter.
  • In the past five years, Preferred Stock Liabilities ranged from a high of $64.0 million in Q4 2013 to a low of $2.0 million in Q4 2015.
  • A 4-year average of $21.9 million and a median of $13.0 million in 2014 frame the typical range for Preferred Stock Liabilities.
  • Annual changes were most pronounced in 2013 — Preferred Stock Liabilities surged 795.48% — and 2015, when it sank 86.67%.
  • Tracing GILD's Preferred Stock Liabilities over 4 years: stood at $7.1 million in 2012, then jumped by 795.48% to $64.0 million in 2013, then sank by 76.56% to $15.0 million in 2014, then slumped by 86.67% to $2.0 million in 2015.
  • The last three Preferred Stock Liabilities figures came in at $2.0 million (Q4 2015), $4.0 million (Q3 2015), and $7.0 million (Q2 2015), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Johnson & Johnson 652.20 Bn 631.44 Bn 17.26 Bn -
2 AbbVie 469.51 Bn 462.94 Bn 12.70 Bn -
3 Merck 376.81 Bn 369.67 Bn 12.21 Bn -
4 Novartis Ag 303.04 Bn 295.35 Bn 11.24 Bn -
5 Astrazeneca 257.61 Bn 252.71 Bn 12.86 Bn -
6 Amgen 237.37 Bn 223.38 Bn 7.24 Bn -
7 Gilead Sciences 181.73 Bn 178.55 Bn 6.22 Bn -
8 Pfizer 159.66 Bn 147.96 Bn 10.94 Bn -
9 Gsk 106.24 Bn 102.07 Bn 8.24 Bn -
10 Sanofi 55.07 Bn 47.69 Bn 10.79 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2015 2.00 Mn
Sep 30, 2015 4.00 Mn
Jun 30, 2015 7.00 Mn
Mar 31, 2015 11.00 Mn
Dec 31, 2014 15.00 Mn
Sep 30, 2014 27.38 Mn
Jun 30, 2014 35.88 Mn
Mar 31, 2014 45.77 Mn
Dec 31, 2013 64.00 Mn
Dec 31, 2012 7.15 Mn